Alerts will be sent to your verified email
Verify Email
KOTYARK
|
Kotyark Industries
|
Nath Bio-Genes
|
Indo US Bio-Tech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
22.18 % | 5.32 % | 15.59 % |
|
5yr Avg Net Profit Margin
|
8.23 % | 3.69 % | 10.35 % |
|
Price to Book
|
0.0 | 0.51 | 3.8 |
|
P/E
|
24.0 | 7.73 | 16.77 |
|
5yr Avg Cash Conversion Cycle
|
113.93 Days | 624.86 Days | 360.66 Days |
|
5yr Average Interest Coverage Ratio
|
12.26 | 2.84 | 5.59 |
|
5yr Avg ROCE
|
28.83 % | 11.39 % | 17.4 % |
|
5yr Avg Operating Profit Margin
|
14.45 % | 14.56 % | 13.37 % |
|
5 yr average Debt to Equity
|
0.35 | 0.21 | 0.37 |
|
5yr CAGR Net Profit
|
20.77 % | 26.86 % | 26.67 % |
|
5yr Average Return on Assets
|
16.72 % | 2.21 % | 9.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.76 % | 45.6 % | 70.17 % |
|
Share Pledged by Promoters
|
0.0 | 13.78 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-4.46 % | 4.53 % | -2.84 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | -2.37 % | 0.0 |
|
Kotyark Industries
|
Nath Bio-Genes
|
Indo US Bio-Tech
|
|---|